Prospective Clinicogenomic Program

Clinical trial NCT04180176 · COMPLETED

Trial details

NCT number: NCT04180176
Sponsor: Genentech, Inc.
Status: COMPLETED
Phase: Phase 4
Study type: INTERVENTIONAL

Non-Small Cell Lung Cancer (NSCLC)Small-Cell Lung Cancer (SCLC)

Start date: 2019-12-13
Primary completion: 2023-11-30
Enrollment: 945

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.